Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule

Gene Therapy

Volumn 6, Issue 6, 1999, Pages 1064-1072

  Biroccio, A ^a   Del Bufalo, D ^a   Ricca, A ^a   D'Angelo, C ^a   D'Orazi, G ^a   Sacchi, A ^a   Soddu, S ^a   Zupi, G ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

BCNU; Gene therapy; Glioblastoma; wt p53

Indexed keywords

CARMUSTINE; PROTEIN P53;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE THERAPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; GENE THERAPY; GENES, P53; GLIOBLASTOMA; HUMANS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE;

EID: 0033058950     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300935     Document Type: Article

References (44)